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Introduction {#sec001}
============

Malaria is a devastating disease of tropical and subtropical regions. Requiring a mammalian host and a mosquito vector for transmission, at least six species of the genus *Plasmodium* cause disease in humans, with *Plasmodium falciparum* being responsible for the great majority of mortality. All the manifestations of clinical disease result from repeated cycles of invasion, replication within and lytic egress from red blood cells (RBC). Invasion is an orchestrated process, comprising several steps including merozoite attachment, deformation of the RBC membrane, merozoite reorientation, formation of a high affinity interaction between the apical zone of the merozoite and the RBC surface, active entry, and finally sealing of the RBC membrane behind the intracellular parasite \[[@ppat.1008049.ref001]--[@ppat.1008049.ref003]\]. Invasion is generally immediately followed by a period of transient RBC echinocytosis, a morphological transformation of the RBC surface into an undulated or 'spiky' appearance, although this can also be induced under certain conditions even in the absence of successful invasion \[[@ppat.1008049.ref003]--[@ppat.1008049.ref005]\]. Entry into the host cell occurs concomitantly with formation of a membrane-bound parasitophorous vacuole (PV) within which the invading parasite comes to rest. The parasite then transforms within minutes into a 'ring' stage form before initiating intracellular development, progressing through a mononuclear trophozoite stage to a multinucleated schizont which undergoes segmentation to form a new generation of daughter merozoites. Parasite-induced rupture of the PV membrane (PVM) and host RBC membrane eventually enables egress of the merozoites to initiate a fresh erythrocytic cycle.

Egress and invasion involve the regulated discharge of at least four classes of secretory organelles--rhoptries, micronemes, exonemes and dense granules---that are unique to apicomplexan parasites and that are positioned within the apical end of the merozoite \[[@ppat.1008049.ref006]\]. The largest of these organelles, the rhoptries, are twinned club or pear-shaped structures that are formed *de novo* during each blood-stage life cycle by progressive fusion of post-Golgi vesicles, with the possible involvement of an endosome-like pathway \[[@ppat.1008049.ref007]--[@ppat.1008049.ref009]\]. Rhoptries are characterised by a relatively wide bulb region which narrows to a neck or duct towards the apical prominence of the merozoite; rhoptry discharge takes place via the duct. Despite the bulb and neck regions not being separated by a discernible membranous boundary, examination by transmission electron microscopy (TEM) has shown a distinct sub-compartmentalisation of each rhoptry, with the bulb and neck regions displaying different staining characteristics in both *Plasmodium* \[[@ppat.1008049.ref007]\] and the related apicomplexan parasite *Toxoplasma gondii* \[[@ppat.1008049.ref010]\]. Based on the detailed examination of the fate of a subset of rhoptry neck proteins (RONs; \[[@ppat.1008049.ref011]\]) and bulb proteins, it has been suggested that the contents of the different rhoptry sub-compartments are released at different points in the invasion pathway, with the RONs being discharged before rhoptry bulb proteins \[[@ppat.1008049.ref012]\]. Consistent with this, several RON proteins have been extensively implicated in the early stages of host cell entry, notably in formation of the moving junction or tight junction (TJ), a short-lived doughnut-shaped structure through which the parasite passes as it enters the host cell (e.g. \[[@ppat.1008049.ref013]--[@ppat.1008049.ref017]\]) Some members of the *P*. *falciparum* reticulocyte binding protein homologue (RH) family of RBC adhesins, which also appear to localise to both the rhoptry bulb and neck \[[@ppat.1008049.ref018]\], also play central roles in early steps in invasion (e.g. \[[@ppat.1008049.ref003], [@ppat.1008049.ref019], [@ppat.1008049.ref020]\]). However, the association between function, timing of discharge and compartmentalisation within the rhoptries may not be a strict one, since the *Plasmodium*-specific protein RON12 is predominantly released post-invasion, into the nascent PV \[[@ppat.1008049.ref021]\]. Similarly, a rhoptry bub location does not preclude roles during invasion, since the rhoptry bulb protein RhopH3, a component of the high molecular weight (HMW) RhopH complex, is important for RBC entry \[[@ppat.1008049.ref022]\]. In contrast, RhopH3 and its partner proteins RhopH1/Clag and RhopH2 have additionally been shown to be involved in nutrient uptake during development of the intracellular parasite \[[@ppat.1008049.ref022]--[@ppat.1008049.ref025]\], whilst the rhoptry bulb low molecular weight (LMW) RAP1/RAP2 complex has been implicated in PVM formation \[[@ppat.1008049.ref026]\]. In *Toxoplasma* (but not in *Plasmodium*) several rhoptry bulb proteins are enzymes, including proteases, phosphatases and kinases or pseudokinases, the latter two groups of which dramatically modulate host cell STAT signalling and the immunity-related GTPase (IRG) pathway involved in controlling parasite replication, and play key roles in virulence \[[@ppat.1008049.ref027], [@ppat.1008049.ref028]\]. Collectively, the current evidence points to multiple diverse roles for rhoptry proteins, with a general theme being that rhoptry neck proteins are often but not exclusively involved in host cell entry whilst rhoptry bulb proteins usually fulfil subsequent roles in the life cycle (see \[[@ppat.1008049.ref029]--[@ppat.1008049.ref031]\] for excellent reviews of this subject). Despite these many insights, of the \~60 known and putative *Plasmodium* rhoptry proteins identified through a combination of numerous antibody studies and proteomic analyses of isolated apicomplexan rhoptries \[[@ppat.1008049.ref011], [@ppat.1008049.ref032]--[@ppat.1008049.ref034]\], the molecular functions of very few *Plasmodium* rhoptry proteins have been characterised. Crucially, how the different subclasses of *Plasmodium* rhoptry proteins are selectively delivered to their distinct sub-compartments within the organelle is unknown.

Rhoptry-associated membrane antigen (RAMA) was initially identified in *P*. *falciparum* as a rhoptry bulb-resident protein which is expressed relatively early in the asexual blood stage cycle, before the *de novo* formation of nascent rhoptries \[[@ppat.1008049.ref035], [@ppat.1008049.ref036]\]. Like many other *Plasmodium* rhoptry bulb proteins, RAMA has no obvious orthologue in *Toxoplasma* or other coccidian Apicomplexa. Unique amongst known *Plasmodium* rhoptry proteins, RAMA is associated with the inner (lumenal) face of the rhoptry bulb membrane via a glycosyl phosphatidylinositol (GPI) membrane anchor \[[@ppat.1008049.ref036]\]. Trafficking of RAMA to the rhoptries shares several features of other rhoptry proteins, including transport via the Golgi apparatus and sensitivity to brefeldin A. The \~170 kDa RAMA precursor then undergoes proteolytic processing in the rhoptries or nascent rhoptries, involving removal of an N-terminal segment to generate a mature \~60 kDa form (p60). To gain insights into its function, Topolska and colleagues \[[@ppat.1008049.ref036]\] and Richard et al. (2009) \[[@ppat.1008049.ref037]\] used fluorescent resonance energy transfer (FRET) and immunoprecipitation to demonstrate that RAMA appears to interact with both RhopH3 and RAP1, proteins which are enriched in lipid rafts but that lack lipid anchors. The authors hypothesised that RAMA plays an escorter role in recruiting and trafficking these proteins to the developing rhoptries, and that proteolytic cleavage of RAMA then facilitates their dissociation from the escorter complex. RAMA p60 (but not the RAMA precursor) was detectable in free extracellular merozoites and evidence was also presented that the protein is released from rhoptries at invasion, supported by the observation that a recombinant form of the extreme C-terminal region of RAMA could bind the RBC membrane. However, in newly invaded 'ring' stage parasites, RAMA p60 was found associated with the PVM, indicating that at least some of the protein was transported into the host cell with the invading parasite \[[@ppat.1008049.ref036]\]. Very recent work has suggested that in fact the RAMA-RAP1 complex may itself be cargo for the *Plasmodium* orthologue of sortilin, an integral membrane protein that in mammalian cells acts as an escorter to transport proteins to the lysosomes, endocytic pathway and plasma membrane \[[@ppat.1008049.ref038]\]. This is consistent with a role in rhoptry formation, since in *Toxoplasma* sortilin is required for biogenesis of both rhoptries and a second class of secretory organelle called micronemes \[[@ppat.1008049.ref039]\], and the *P*. *falciparum* sortilin orthologue has been localised to the Golgi \[[@ppat.1008049.ref009]\]. Although restricted to the *Plasmodium* genus, *RAMA* orthologues were identified in all *Plasmodium* species examined \[[@ppat.1008049.ref040]\], and this was subsequently confirmed by the now extensive genome sequence data from numerous additional *Plasmodium* species (see PlasmoDB *RAMA* gene ID: PF3D7_0707300; <https://plasmodb.org/plasmo/>). More recent evidence from targeted or global reverse genetics studies indicates that disruption of the *P*. *falciparum* or *P*. *berghei RAMA* gene is deleterious or lethal \[[@ppat.1008049.ref041]--[@ppat.1008049.ref043]\], consistent with an important role for RAMA in the asexual blood stage parasite life cycle. However, the molecular function of RAMA has remained obscure.

Here we have used a robust conditional mutagenesis approach to examine the function of RAMA in the *P*. *falciparum* asexual blood stage life cycle. In contrast to previous suggestions, we found that disruption of RAMA expression does not affect trafficking of the rhoptry bulb proteins RhopH3 and RAP1, nor biogenesis of the rhoptry bulb. Instead, our results indicate a selective role for RAMA in formation of the rhoptry neck structure. Perhaps as a result, the RAMA mutants show mislocalisation of several RON proteins and a lethal defect in host RBC invasion.

Results {#sec002}
=======

Efficient conditional disruption of the *P*. *falciparum RAMA* gene {#sec003}
-------------------------------------------------------------------

Previous attempts to directly disrupt the *P*. *falciparum RAMA* gene using conventional targeted genetic techniques were unsuccessful \[[@ppat.1008049.ref041]\], suggesting an important role for RAMA in the haploid asexual blood stages. To gain insights into the molecular function of RAMA we therefore used a conditional gene disruption approach based on the rapamycin-inducible DiCre conditional recombinase system. To enable this, we first modified the *RAMA* gene in the DiCre-expressing 1G5DC *P*. *falciparum* line \[[@ppat.1008049.ref044]\] to introduce 'silent' *loxP* motifs suitable to act as sites for DiCre-mediated site-specific recombination. The *RAMA* gene encodes an 861 amino acid residue protein and comprises 4 small exons plus a single much larger exon (exon 2). The complexity and relatively large size (\~3.2 kb) of the *RAMA* locus precluded facile floxing of the entire coding sequence in a single manipulation as previously performed with other *P*. *falciparum* genes \[[@ppat.1008049.ref004]\], so we took an alternative approach in which we inserted into exon 2 a synthetic construct combining two heterologous *loxPint* elements (i.e. synthetic introns each containing a *loxP* site; \[[@ppat.1008049.ref045]\]), flanking 176 bp of intervening recodonised exon sequence. The inserted sequence was precisely integrated in a marker-free manner in a single Cas9-promoted homologous recombination step ([Fig 1A](#ppat.1008049.g001){ref-type="fig"}). The resulting modified *RAMA* gene (referred to as *RAMAloxP*) thus effectively comprised 7 exons with an internal recodonised exon flanked by *loxPint* sequences. DiCre-mediated recombination between the introduced *loxP* sites was predicted to excise this exon. Importantly, excision was also expected to create a frame-shift in the coding sequence immediately downstream of the single chimeric *loxPint* site remaining after excision, leading to a severely truncated *RAMA* coding sequence encoding only the N-terminal 220 residues, referred to below as RAMAΔE2.

![Conditional disruption of the *P*. *falciparum RAMA* gene.\
(A) The *RAMA* gene (PlasmoDB PF3D7_0707300) comprises 5 exons (numbered grey boxes; not to scale) and 4 introns (blue lines). Two AG-AT motifs (splice site junction consensus sequences; \[[@ppat.1008049.ref072]\] in exon 2, separated by 176 bp, were chosen as the location for insertion of two *loxP*-containing (purple arrowhead) heterologous introns (*SERA2*:*loxPint*, blue line; *SUB2*:*loxPint*, pink line) flanking a recodonised form of the intervening 176 bp coding sequence (E2 recod, green box). The integration sequence, provided on repair construct pESS_RAMA_E2INT_loxP, was inserted by double crossover homologous recombination between homology arms (E2H1 and E2H2), facilitated using Cas9 and sgRNAs encoded on a separate plasmid to generate a targeted double stranded break (see [Materials and methods](#sec009){ref-type="sec"}). DiCre-mediated recombination between the *loxP* sites in the modified *RAMAloxP* locus was expected to excise the E2 recod sequence, leaving only a single chimeric *SERA2*:*loxP*:*SUB2* intron on the chromosome and generating a frame-shift following the first 220 amino acid codons of the *RAMA* coding sequence. Positions of primers used for diagnostic PCR are indicated (half arrows; see [S1 Table](#ppat.1008049.s003){ref-type="supplementary-material"} for numerical codes and sequences of all primers used in this study), as are XmnI restriction sites (X) used for Southern blot analysis. The grey dotted line indicates the region used for hybridisation of a probe for Southern blot. (B) PCR analysis of *RAMAloxP* clones 9C10 and 12C7 confirmed the expected gene modification events. Amplicons diagnostic of the wild type locus obtained from parental 1G5DC parasites (wild type; wt) were not amplified from the *RAMAloxP* clones. Primer identities are colour-coded as in panel (A). (C) Southern blot; XmnI-digested genomic DNA from *RAMAloxP* clones 9C10 and 12C7 was hybridised with a probe specific for the E2H2 sequence. Expected fragment sizes are 2,191 bp (wt) and 1,050 bp (*RAMAloxP*). (D) Diagnostic PCR showing efficient RAP-induced excision of the floxed sequence in the *RAMAloxP* parasite clones, leading in both cases to the expected decrease in amplicon size from 594 bp to 304 bp. Primer identities are colour-coded as in panel (A). (E) Immunoblots of SDS PAGE-fractionated cycle 0 schizont extracts probed with anti-RAMA-D antibodies (raised against residues 482--758 of the RAMA sequence; \[[@ppat.1008049.ref036]\]). Loss of RAMA p60 expression (arrowed) was almost complete in the RAP-treated *RAMAloxP* parasites. Similarly-treated 1G5DC schizonts (wt) were analysed in parallel to confirm that RAP-treatment has no effect on RAMA expression in the absence of the *RAMAloxP* modification. The blots were stripped and re-probed with anti-BiP antibodies as a loading control (lower panels). (F) Representative IFA images demonstrating loss of RAMA expression upon RAP-treatment of *RAMAloxP-*9C10 parasites. Cycle 0 schizonts were co-stained with anti-RAMA-D antibodies and the anti-RAP1 monoclonal antibody (mAb) 4F3. 4,6-diamidino-2-phenylindole (DAPI) was used as a DNA stain. The great majority of RAP-treated parasites (\>99.8% as calculated from exhaustive examination of 1,002 schizonts by IFA) showed no detectable anti-RAMA-D staining, but the RAP1 signal remained unaffected. Scale bars, 5 μm.](ppat.1008049.g001){#ppat.1008049.g001}

Limiting dilution cloning of the transfected parasite population resulted in the isolation of 2 parasite clones called *RAMAloxP*-9C10 and *RAMAloxP*-12C7, each independently generated using different sgRNAs. The expected modification of the native *RAMA* locus was confirmed in both parasite clones by diagnostic PCR ([Fig 1B](#ppat.1008049.g001){ref-type="fig"}) and Southern blot ([Fig 1C](#ppat.1008049.g001){ref-type="fig"}) and the clones were therefore used for all subsequent experiments. Growth assays comparing replication rates of *RAMAloxP*-9C10 and *RAMAloxP*-12C7 parasites with the parental 1G5DC line revealed no significant differences, indicating that the modifications made to the *RAMA* gene did not detectably impair parasite growth ([S1 Fig](#ppat.1008049.s001){ref-type="supplementary-material"}).

To examine the efficiency of conditional excision of the floxed *RAMA* sequence, tightly synchronised newly-invaded ring stage cultures of both the *RAMAloxP* clones were divided into two and treated for just 4 h with either rapamycin (RAP; 100 nM final) or DMSO vehicle control (1% v/v, mock-treated). Following washing and further incubation for \~44 h to allow maturation to mature schizont stage, parasite genomic DNA (gDNA) was extracted and examined by analytical PCR. This revealed highly efficient RAP-induced excision of the floxed *RAMA* sequence ([Fig 1D](#ppat.1008049.g001){ref-type="fig"}). To determine the impact of excision on RAMA expression, the schizonts were analysed using a rabbit polyclonal antibody called anti-RAMA-D, specific for a C-terminal segment (amino acid residues 482 to 758) of RAMA \[[@ppat.1008049.ref036]\]. As shown in [Fig 1E](#ppat.1008049.g001){ref-type="fig"} and [Fig 1F](#ppat.1008049.g001){ref-type="fig"}, little or no signal was detected by the anti-RAMA-D antibodies in schizonts of the RAP-treated cultures, either by Western blot or by indirect immunofluorescence analysis (IFA). These results confirmed the PCR data, demonstrating in two independent *RAMAloxP* parasite clones essentially complete conditional disruption of RAMA expression within a single erythrocytic cycle.

RAMA is required for *P*. *falciparum* replication *in vitro* {#sec004}
-------------------------------------------------------------

The IFA images in [Fig 1F](#ppat.1008049.g001){ref-type="fig"} indicated that, despite efficient disruption of the *RAMA* gene in RAP-treated *RAMAloxP* parasites, the parasites were able to form multinucleated schizonts towards the end of the erythrocytic growth cycle in which they were RAP-treated (henceforth referred to as cycle 0). To examine the effects of gene disruption on longer-term parasite viability, the mock- and RAP-treated *RAMAloxP* clones were maintained in culture and parasite replication monitored by flow cytometry over the ensuing erythrocytic cycles. Mock- and RAP-treated parental 1G5DC parasites were also included in these experiments to control for any off-target effects of RAP treatment. As shown in [Fig 2A](#ppat.1008049.g002){ref-type="fig"}, a dramatic reduction in parasite replication rate was quickly evident in the RAP-treated *RAMAloxP* parasites, indicating a defect in parasite proliferation. This was confirmed by diagnostic PCR ([Fig 2B](#ppat.1008049.g002){ref-type="fig"}) which revealed that upon passage of the cultures for up 9 erythrocytic cycles, the excised locus quickly became undetectable in RAP-treated cultures (indicating disappearance of the RAMAΔE2 mutants) whilst in contrast the initially very minor fraction of non-excised parasites gradually expanded to take over the cultures. This was consistent with an acute fitness defect in the RAMAΔE2 mutants. A further quantitative assessment of the impact of *RAMA* disruption upon parasite viability was obtained by comparing the capacity of mock- and RAP-treated *RAMAloxP* parasites to form zones of erythrocyte lysis, or plaques \[[@ppat.1008049.ref046]\], in static cultures in flat-bottomed microplates ([Fig 2C](#ppat.1008049.g002){ref-type="fig"}). This showed that RAP-treatment of both the *RAMAloxP*-9C10 and *RAMAloxP*-12C7 clones produced a highly significant reduction in plaque formation; the mean relative plaque forming capacity (RPFC) of RAP-treated parasites was 3.39% ± 0.833 (meaning that for every 10,000 plaques produced by the control mock-treated cultures, only 339 were formed in the same number of RAP-treated culture-containing wells) (p = 3.32 x 10^−8^, t = 115.9, d.f. = 4). Together, these data confirmed that RAMA plays a critical role in *P*. *falciparum* asexual blood stage viability.

![RAMA is required for asexual blood stage *P*. *falciparum* replication.\
(A) Replication of *RAMAloxP* and parental 1G5DC parasites over the course of 4--5 erythrocytic cycles following mock-treatment (DMSO) or RAP-treatment of synchronous ring-stage cultures. Parasitaemia values (quantified by flow cytometry) were averaged from three biological replicate experiments performed using blood from different donors, and are presented as mean ± SD. Post-hoc comparisons by three-way ANOVA revealed significant differences between growth curves of the mock- and RAP-treated *RAMAloxP* clones 9C10 (p = 0.00995) and 12C7 (p = 0.00860), but not of the parental 1G5DC line (p = 0.998). (B) Diagnostic PCR analysis of mock- or RAP-treated cultures of *RAMAloxP* clone 9C10 parasites, indicating gradual overgrowth of the excised population by an initially undetectable minority of non-excised parasites. Parasite gDNA sampled at each cycle over the course of 9 erythrocytic growth cycles was analysed (see [Fig 1A](#ppat.1008049.g001){ref-type="fig"} for primer identities). The signal specific for the excised locus became less intense with time whilst the signal specific for the non-excised locus increased in intensity, eventually becoming the sole PCR amplicon detectable. (C) Plots comparing plaque formation by mock- and RAP-treated cultures of *RAMAloxP* clones 9C10 and 12C7. Cultures were dispensed into flat-bottomed microwell plates at equivalent parasite densities and plaques scored following static incubation for 14 days. Error bars represent ± 1 SD from two independent experiments in blood from different donors. A total of 180 wells were used for each treatment in each replicate of the assay.](ppat.1008049.g002){#ppat.1008049.g002}

Disruption of RAMA produces an invasion defect {#sec005}
----------------------------------------------

Given the established role of rhoptries in invasion, we considered that the replication defect shown by the RAMAΔE2 parasites might most likely be explained by a reduced capacity to invade host cells. To investigate this, mature *RAMAloxP*-9C10 and *RAMAloxP*-12C7 cycle 0 schizonts were isolated from highly synchronous mock- or RAP-treated cultures then added to fresh RBCs to achieve a similar starting parasitaemia. Following further incubation for 4 h to allow schizont rupture, the cultures were stained with Hoechst 33342 and the proportions of newly-invaded ring-stage parasites determined by flow cytometry. This consistently showed that the RAP-treated parasites displayed substantially reduced ring formation, corresponding to only \~10% of that of mock-treated parasites ([Fig 3A](#ppat.1008049.g003){ref-type="fig"}).

![Disruption of RAMA results in an invasion defect.\
(A) Reduced ring formation by RAMA mutants. Mature cycle 0 schizonts isolated from mock- or RAP-treated cultures of the indicated clones were incubated with fresh RBCs and ring-stage parasitaemia determined 4 h later by flow cytometry. Data were averaged from three biological replicate experiments, using blood from different donors. Error bars, ± 1 SD. Statistical significance was determined by a two-tailed unpaired t-test where p≤0.0001, \*\*\*\* and p\>0.05, non-significant (ns). Ring formation by the parental 1G5DC parasites was unaffected by RAP treatment (t = 0.507, d.f. = 4, p = 0.639). (B) Still images from experiments monitoring egress of merozoites by time-lapse DIC microscopy of mature mock- and RAP-treated *RAMAloxP* clone 9C10 schizonts. Highly synchronous cycle 0 schizonts were incubated with the parasite cGMP-dependent protein kinase G inhibitor (4-\[7-\[(dimethylamino)methyl\]-2-(4-fluorphenyl)imidazo\[1,2-α\]pyridine-3-yl\]pyrimidin-2-amine (compound 2; C2) for 4 h to reversibly arrest egress \[[@ppat.1008049.ref073]\]. Immediately after washing away the C2 the parasites were monitored for 30 minutes. No delay in egress was observed in the RAP-treated population, and there were no discernible differences in egress efficiency or morphology. Time in minutes from commencement of microscopy is indicated. Scale bar, 10 μm. Images shown are from clone 9C10 but are representative of 3 independent replicate experiments examining *RAMAloxP* clones 9C10 and 12C7. (C) Quantification of invasion, merozoite-induced RBC surface deformation and echinocytosis observed by video microscopy following rupture of mock- or RAP-treated *RAMAloxP* clone 9C10 schizonts. At least 20 videos per condition were quantified. Statistical significance was assessed by t-test; ns indicates not significant (p \> 0.05) whereas \*\*\*\* indicates p \< 0.0001. The RAP-treated (RAMAΔE2) merozoites interacted with and deformed target RBCs, but neither invaded them nor induced echinocytosis. See also [S1 Movie](#ppat.1008049.s004){ref-type="supplementary-material"} and [S2 Movie](#ppat.1008049.s005){ref-type="supplementary-material"}.](ppat.1008049.g003){#ppat.1008049.g003}

As egress and invasion are intimately linked, we explored whether the lack of ring formation in these assays was indicative of a defect in egress from the host erythrocyte. To do this the capacity of RAMAΔE2 parasites to undergo egress was examined by time-lapse differential interference contrast (DIC) microscopy. As shown in [Fig 3B](#ppat.1008049.g003){ref-type="fig"}, no detectable differences in the efficiency, kinetics or morphology of merozoite egress from RAP-treated *RAMAloxP* parasites was evident compared to their mock-treated counterparts. It was concluded that disruption of RAMA does not affect egress, but results in a severe defect in productive invasion of new host erythrocytes.

To characterize this invasion defect in further detail, the behaviour of naturally-released merozoites and their interactions with host RBCs was examined by time-lapse DIC video microscopy. As shown in [S1 Movie](#ppat.1008049.s004){ref-type="supplementary-material"} and [S2 Movie](#ppat.1008049.s005){ref-type="supplementary-material"}, and quantified in [Fig 3C](#ppat.1008049.g003){ref-type="fig"}, merozoites released from RAP-treated (RAMAΔE2) cycle 0 schizonts interacted initially with neighbouring host RBCs in a similar manner to their mock-treated *RAMAloxP* counterparts, inducing repeated and often strong deformation of the host cells. However, unlike the mock-treated merozoites, in no case (out of a total of 20 similar egress events examined) did we observe successful invasion by the RAMAΔE2 merozoites. Of particular additional interest, no RBC echinocytosis was ever observed in the case of the RAMAΔE2 merozoite-RBC interactions. Echinocytosis generally takes place shortly following invasion (see [S1 Movie](#ppat.1008049.s004){ref-type="supplementary-material"}), but under certain conditions can also occur in the absence of invasion, where it is thought to indicate discharge of rhoptry components \[[@ppat.1008049.ref003]--[@ppat.1008049.ref005]\]. It was concluded that loss of RAMA selectively results in a fatal block in invasion, likely due to a defect in rhoptry discharge.

Disruption of RAMA leads to mislocalisation of some but not all rhoptry neck and rhoptry bulb proteins {#sec006}
------------------------------------------------------------------------------------------------------

As mentioned above, morphological characterisation of mature cycle 0 RAMAΔE2 schizonts by light microscopy (IFA) indicated apparently normal schizont development ([Fig 1F](#ppat.1008049.g001){ref-type="fig"}). However, given the clear invasion phenotype displayed by the RAMAΔE2 mutants and the known rhoptry bulb localisation of RAMA \[[@ppat.1008049.ref036]\], we decided to examine the structure of the mutant parasites in greater detail to assess the possible impact of RAMA disruption on the makeup and morphology of the rhoptries. This was considered particularly important given previous claims that RAMA interacts with RhopH3 and RAP1 and plays a role in the trafficking of both proteins to the rhoptries \[[@ppat.1008049.ref036], [@ppat.1008049.ref037]\].

To determine the effects of RAMA disruption on the expression and trafficking of other rhoptry proteins, mature cycle 0 schizonts from mock-treated and RAP-treated *RAMAloxP* cultures were probed by IFA using a suite of antibodies specific for a range of rhoptry bulb proteins. As shown in [Fig 4A](#ppat.1008049.g004){ref-type="fig"}, this revealed that the subcellular localisation and staining intensity of the LMW rhoptry complex protein RAP2, the HMW rhoptry complex proteins RhopH1/Clag3.1, RhopH2 and RhopH3, the invasion ligand Rh5, and the rhoptry-associated protein ARO (thought to localise to the cytosolic face of the rhoptry bulb and neck \[[@ppat.1008049.ref047]--[@ppat.1008049.ref049]\]) were unaffected by RAMA disruption; all retained their characteristic apical punctate rhoptry signal in the RAP-treated *RAMAloxP* schizonts. Note that similar findings were noted above for RAP1 ([Fig 1F](#ppat.1008049.g001){ref-type="fig"}). It was concluded that truncation of RAMA does not discernibly affect the trafficking of a number of established rhoptry bulb proteins.

![Disruption of RAMA leads to selective mislocalisation of some but not all rhoptry proteins.\
(A) IFA showing that the staining profile of RAP2, RhopH1/Clag3.1, Rh5, RhopH2, ARO and RhopH3 was unaltered between DMSO- and RAP-treated *RAMAloxP* clone 9C10 schizonts. Scale bar, 2 μm. (B) IFA showing that, whilst RhopH3 and RhopH1/Clag3.1 staining was unaffected by RAMA disruption, RON2, RON3 and RON4 staining was modified in RAP-treated *RAMAloxP* clone 9C10 schizonts. In all cases, the staining was much weaker in the RAMAΔE2 parasites and lacked the characteristically punctate, apically-disposed pattern typical of rhoptry staining. Scale bar, 2 μm. (C) The extent of RON protein mis-trafficking depends on the maturity of the RAP-treated *RAMAloxP* schizonts. Whilst some signal was still detectable in less mature schizonts (those with fewer nuclei), the RON2, RON3 and RON4-specific signal was absent or much reduced in the mature segmented schizonts (examples indicated with arrows). Note that these images are of lower magnification that those shown in the rest of the figure in order to display multiple schizonts in each field. Scale bar, 10 μm. (D) Schizonts of DMSO- and RAP-treated *RAMAloxP* clone 9C10 were probed with a polyclonal antibody against AMA1 as well as anti-MSP1 antibodies. AMA1 localisation (upper panel) and discharge onto the merozoite surface in mature schizonts (lower panel) was unaffected by RAMA disruption. Scale bar, 2 μm. Parasite nuclei were visualised throughout by staining with DAPI.](ppat.1008049.g004){#ppat.1008049.g004}

To examine the effects of RAMA truncation upon the subcellular localisation of RON proteins, mock- and RAP-treated *RAMAloxP* schizonts were next probed with antibodies specific for RON2 \[[@ppat.1008049.ref050]\], RON3, or RON4 \[[@ppat.1008049.ref051]\]. As shown in [Fig 4B](#ppat.1008049.g004){ref-type="fig"} and [Fig 4C](#ppat.1008049.g004){ref-type="fig"}, in all cases this revealed evidence for RON protein mislocalisation in the RAMAΔE2 mutants, although the precise phenotype appeared to depend upon the extent of parasite maturity. Specifically, for all three RON proteins, in immature schizonts a much reduced signal intensity was detectable which lacked the punctate, apically-disposed pattern typical of rhoptries. In highly mature segmented schizonts, IFA signals for RON2, RON3 and RON4 were often completely absent. These findings were particularly intriguing since, whilst RON2 and RON4 are established rhoptry neck proteins that play roles in TJ formation, RON3 has been localised by immuno electron microscopy to the rhoptry bulb in *Plasmodium* \[[@ppat.1008049.ref052]\], rather than to the rhoptry neck as originally determined for the *Toxoplasma* orthologue \[[@ppat.1008049.ref011]\]. Work in *Toxoplasma* also supports a rhoptry bulb location (see ToxoDB annotation for the *TgRON3* gene at <https://toxodb.org/toxo/app/record/gene/TGME49_223920>). The current nomenclature for RON3 is therefore somewhat misleading, and these results therefore suggested that disruption of RAMA expression can modulate the localisation of rhoptry neck proteins as well as at least one rhoptry bulb protein.

To investigate this issue further using additional rhoptry markers, we examined *RAMAloxP* schizonts by IFA using antibodies to two proteins that have been previously localised to either the rhoptry neck (RON12; \[[@ppat.1008049.ref021]\]) or both the rhoptry body and the neck (Rh2b; \[[@ppat.1008049.ref018]\]) in *P*. *falciparum* merozoites. As shown in [S2 Fig](#ppat.1008049.s002){ref-type="supplementary-material"} and in contrast to the effects on RON2, RON3 and RON4, disruption of RAMA expression had no discernible effect on expression or localisation of either RON12 or Rh2b.

As expected, disruption of RAMA did not impact on the localisation of the major merozoite surface protein MSP1 or the microneme protein apical membrane antigen 1 (AMA1) ([Fig 4D](#ppat.1008049.g004){ref-type="fig"}). AMA1 is often observed to translocate onto the merozoite surface in highly mature schizonts, and this phenomenon too was observed at similar frequency in both mock-treated and RAP-treated *RAMAloxP* schizonts ([Fig 4D](#ppat.1008049.g004){ref-type="fig"}, lower panels). Collectively, these results indicated that disruption of RAMA results in selective mislocalisation and/or loss of rhoptry neck and certain rhoptry bulb proteins, whilst having no detectable impact on the expression and trafficking of other rhoptry proteins examined.

RAMA is selectively required for formation of the rhoptry neck {#sec007}
--------------------------------------------------------------

Previous studies of RAMA suggested a role in rhoptry biogenesis \[[@ppat.1008049.ref036]\]. Our discovery that some rhoptry proteins become mislocalised upon RAMA disruption prompted us to next examine the impact of RAMA disruption on rhoptry formation and morphology. To do this, mature segmented cycle 0 mock- or RAP-treated *RAMAloxP* schizonts were examined by TEM. To quantify rhoptry formation, the number of rhoptry profiles detectable in individual intracellular merozoites in 70 nm thin sections was recorded. This revealed no statistically significant differences in the total number of visible rhoptry profiles between the control and RAMAΔE2 parasites (glm fit with Poisson model, predicting rhoptry count from status, non-zero status coefficient test p-value = 0.232) ([Fig 5A](#ppat.1008049.g005){ref-type="fig"}). This result was in complete accord with the IFA results obtained with the rhoptry bulb-specific antibodies described in [Fig 4](#ppat.1008049.g004){ref-type="fig"}, suggesting that the overall number of rhoptry organelles assembled in wild-type and RAMAΔE2 parasites was similar.

![Disruption of RAMA leads to defective rhoptry morphology and reduced rhoptry neck formation.\
Tightly synchronised mature schizonts from DMSO- or RAP-treated cultures of *RAMAloxP* clone 9C10 parasites were fixed and processed for TEM, then three sections from each sample taken and 20 schizonts examined per section. (A) Mean number of visible rhoptry profiles per schizont calculated from each set of 60 TEM images of DMSO-treated and RAP-treated schizonts. There was no statistically significant difference in the mean number of rhoptry profiles visible. Error bars, ±1 SD. p\>0.05, non-significant (ns). (B) Representative TEM images from DMSO and RAP-treated *RAMAloxP* schizonts indicating that club-shaped and circular (i.e. likely spherical) rhoptry profiles were detected in both. Scale bar, 100 nm. (C) The proportion of club-shaped rhoptry profiles visible in DMSO-treated *RAMAloxP* schizonts was greater than that in RAP-treated *RAMAloxP* schizonts. Statistical significance was determined by unpaired t-test. Error bars depict ±1 SD. p≤0.01, \*\*. (D) Plots of aspect ratio (longest diameter divided by shortest diameter) calculated from thin section electron micrographs for all rhoptries (both DMSO and RAP-treated) classified as non-circular. Non-circular rhoptries from DMSO-treated schizonts displayed a higher aspect ratio (i.e. were more elongated) than those from RAP-treated *RAMAloxP* schizonts. Statistical difference determined by two-tailed t-test. Error bars, ±1SD. p≤0.0001, \*\*\*\*. (E) Two dimensional cross section images and three-dimensional models derived from 200 nm thick section serial tomograms acquired from a DMSO-treated (upper two panels) and a RAP-treated *RAMAloxP* schizont (lower two panels). Rhoptries are depicted in various colours to easily distinguish individual structures. Whilst the rhoptries of the DMSO-treated schizonts appear predominantly club shaped, those of the RAP-treated parasites appear much more circular with stubby, non-conoid projections. Scale bars, 500 nm. All observations where zero rhoptry profiles were reported for a merozoite were deemed 'failed' observations for the purposes of this analysis and were not included in the analysis.](ppat.1008049.g005){#ppat.1008049.g005}

During the above analysis, we noticed that whilst other intracellular features of the control and RAP-treated parasites (including microneme morphology) were similar, there was a relative absence of typical club-shaped rhoptry profiles in the RAMAΔE2 TEM micrographs. To attempt to quantify these apparent differences in rhoptry morphology, the TEM rhoptry images were categorised as being either circular or club-shaped based on blinded visual examination ([Fig 5B](#ppat.1008049.g005){ref-type="fig"}). As shown in [Fig 5C](#ppat.1008049.g005){ref-type="fig"}, whilst rhoptries of both shapes were observed in merozoites of mock-treated and RAP-treated *RAMAloxP* parasites, a significantly lower proportion of club-shaped profiles was observed in the RAMAΔE2 samples. Moreover, in those RAMAΔE2 rhoptries that visibly possessed an apical projection, these appeared qualitatively different from wild type, being relatively short and stubby compared to the elongated projections typical of the latter ([Fig 5B](#ppat.1008049.g005){ref-type="fig"}). This difference in shape was confirmed by quantifying the aspect ratio (the ratio of the longest to shortest diameter) in the electron micrographs of all non-circular rhoptries from both control and RAP-treated parasites. The resulting data ([Fig 5D](#ppat.1008049.g005){ref-type="fig"}) clearly indicated that the length of the rhoptry neck projections in control parasites (mean aspect ratio = 1.73) was significantly greater than those of RAP-treated parasites (mean aspect ratio = 1.21) (p \<0.0001, t = 5.29, d.f. = 58). Since these profiles represent random section planes through rhoptries, it was considered unlikely that the differences noted were a chance result of random variation in the section plane obtained during sample preparation. However, to finally examine this point, electron tomography was performed on serial 200 nm thick sections of a single mock-treated *RAMAloxP* schizont and a RAP-treated *RAMAloxP* schizont ([S3 Movie](#ppat.1008049.s006){ref-type="supplementary-material"} and [S4 Movie](#ppat.1008049.s007){ref-type="supplementary-material"}). This allowed computational three-dimensional modelling of much of the rhoptry content of each schizont by segmentation and rendering of the tomograms. The resulting models ([Fig 5E](#ppat.1008049.g005){ref-type="fig"}) supported the thin section TEM data in showing a clear difference between the elongated shape of rhoptries in the DMSO-treated *RAMAloxP* schizonts and the strikingly more spherical nature of the RAMAΔE2 rhoptries.

Collectively, our EM data indicated that disruption of RAMA does not affect the number of rhoptries formed, but has a major impact on their morphology, leading to the generation of relatively spherical or 'neckless' rhoptries. This may explain why certain rhoptry neck proteins mislocalise in the RAMA mutants.

Discussion {#sec008}
==========

The involvement of rhoptry proteins in host cell entry has long been proposed, supported by early observations that rhoptry discharge coincides temporally with invasion in several apicomplexan parasites, including *Toxoplasma* \[[@ppat.1008049.ref053]--[@ppat.1008049.ref056]\] and *P*. *falciparum* \[[@ppat.1008049.ref017]\]. Those studies have been burgeoned by recent demonstrations that correct positioning of rhoptries at the apical pole of the *Toxoplasma* tachyzoite is a prerequisite for invasion (but not egress) \[[@ppat.1008049.ref048]\] whilst in both *P*. *falciparum* merozoites and *Toxoplasma* tachyzoites rhoptries appear to undergo fusion with each other during invasion \[[@ppat.1008049.ref030], [@ppat.1008049.ref057]\]. The discovery of the role of several RON proteins in TJ formation \[[@ppat.1008049.ref015], [@ppat.1008049.ref016]\] was consistent with this overall model for rhoptry function, but as discussed in the Introduction it is also now clear that rhoptry proteins play roles following completion of invasion in such diverse functions as PVM generation, subversion of host cell signalling, and nutrient acquisition. Here we have established a new role for a *Plasmodium* rhoptry protein in biogenesis of these important organelles.

We draw three major conclusions from our study. First, we have shown that RAMA is essential for parasite survival, and that disruption of RAMA expression results in a selective, fatal defect in host cell invasion with no obvious effect on intracellular parasite replication or egress. This finding is reminiscent of the results of conditional ablation in *Toxoplasma* of ARO, a palmitoylated protein localised to the cytoplasmic rhoptry surface which is essential for correct tethering of the rhoptries within the tachyzoite apex \[[@ppat.1008049.ref047]--[@ppat.1008049.ref049]\]. Loss of TgARO results in rhoptries that are dispersed throughout the cytoplasm of the parasite, and the mutant tachyzoites undergo normal egress but cannot invade host cells. As well as not being able to penetrate targeted RBCs, we found that RAMAΔE2 merozoites showed no capacity to induce echinocytosis in interacting RBCs. This provides important insights into the underlying defect. Evidence that rhoptry discharge can take place upon contact with the host cell even in the absence of productive invasion was first demonstrated through observations of the appearance of small nascent intraerythrocytic channels or vacuoles at the site of apical attachment of *P*. *knowlesi* merozoites to the RBC surface; this occurred both under normal, invasion-permissive conditions but also in cultures containing cytochalasin B, an inhibitor of actin polymerisation that blocks invasion downstream of TJ formation \[[@ppat.1008049.ref058]--[@ppat.1008049.ref060]\]. Subsequent work in *P*. *falciparum* combining electron microscopy with super-resolution immunofluorescence microscopy showed that these vacuoles contain rhoptry proteins \[[@ppat.1008049.ref013]\]. Similar structures (termed 'evacuoles' when formed in the presence of cytochalasin) were observed upon interaction of *Toxoplasma* tachyzoites with host cells, and these were also found to contain large amounts of rhoptry bulb proteins \[[@ppat.1008049.ref053], [@ppat.1008049.ref061]\]. More recent comprehensive microscopic examination of the interactions between free *P*. *falciparum* merozoites and host RBCs provided evidence that rhoptry discharge is the primary inducer of echinocytosis in target RBCs \[[@ppat.1008049.ref003]\], and consistent with the above observations this can occur even in the absence of productive invasion. Very recent work has added further support to this model, showing that merozoites genetically deficient in key components of the cyclic nucleotide signalling pathway or the molecular motor that drives invasion can induce echinocytosis in target RBCs, despite being unable to penetrate the cells \[[@ppat.1008049.ref004], [@ppat.1008049.ref005]\]. It has thus become clear that host RBC echinocytosis---irrespective of whether it is followed by successful invasion---provides a useful reporter for rhoptry function in *Plasmodium*. In our current study, the complete absence of echinocytosis upon interactions between RAMAΔE2 merozoites and target RBCs is therefore completely consistent with a defect in rhoptry discharge and/or the absence of the (currently unidentified) rhoptry component(s) that induce echinocytosis. RAMA was previously proposed to act as an invasion ligand based on indications that anti-RAMA antibodies inhibit merozoite invasion of RBCs \[[@ppat.1008049.ref036]\] and that recombinant RAMA-based peptides could apparently bind to RBCs and inhibit invasion \[[@ppat.1008049.ref062]\]. Our study did not directly address this proposed function for RAMA.

The second clear conclusion from our study is that RAMA is not required for correct trafficking of RAP1 or RhopH3, as previously proposed based on protein-protein interaction and co-localisation studies \[[@ppat.1008049.ref036]--[@ppat.1008049.ref038]\], nor for trafficking of several other rhoptry bulb proteins examined. Our results are therefore not consistent with a rhoptry bulb-specific protein escorter role for RAMA. However, our findings may not necessarily be in conflict with the interaction model; RAMA may associate with RhopH3 and RAP1, for example, in order to facilitate formation of the respective HMW and LMW complexes, whilst other factors may regulate localisation of these protein complexes to the rhoptry bulb. It is important to note that our RAMA disruption strategy did not remove the entire gene and could in principle result in the expression of the N-terminal 220 residues of the protein as a truncated protein product ([Fig 1](#ppat.1008049.g001){ref-type="fig"}). We did not have the antibody tools to detect whether such a truncated product was expressed in our mutants. However, were it to be expressed, the truncated protein would lack the C-terminal sequences between residues 315--840 previously shown to interact with RAP1 and sortilin, and required for trafficking to the rhoptries \[[@ppat.1008049.ref036]--[@ppat.1008049.ref038]\]. We are therefore confident that our strategy generated a loss-of-function mutant, and the phenotype supports that.

Third, our results show that RAMA is instead required for correct localisation of a subset of RON and rhoptry bulb proteins and for formation of the rhoptry neck, providing the first genetic evidence that RAMA plays an essential role in rhoptry biogenesis. The causal relationship between these phenotypes is unclear, in that we cannot discriminate between whether a defective rhoptry morphology leads to mislocalisation of the RON proteins or alternatively whether correct trafficking of RON proteins is required for rhoptry neck morphogenesis. RAMA may interact with RON proteins to ensure their correct trafficking, although no associations between RAMA and RON proteins were identified in the earlier studies \[[@ppat.1008049.ref036], [@ppat.1008049.ref037]\]. The involvement of a rhoptry bulb protein in trafficking of rhoptry neck proteins appears somewhat counterintuitive. Could RAMA direct these proteins to the bulb then regulate their onward trafficking to the nascent neck domain? It is interesting to note that RON12, a rhoptry neck protein localisation of which was unaffected by RAMA disruption in this study, has very recently been confirmed as a rhoptry neck protein in merozoites of the rodent malaria parasite *Plasmodium berghei*, but a rhoptry bulb protein in *P*. *berghei* sporozoites, a developmental stage of the parasite generated in the mosquito vector \[[@ppat.1008049.ref063]\]. This suggests that the trafficking characteristics of rhoptry proteins may not be an intrinsic function of their structure *per se*, but dependent upon the developmental context of their expression.

Both RON2 and RON4 are key for formation of the TJ, so their mis-trafficking may explain in part the invasion defect in the RAMAΔE2 mutants. However, we propose that the most dramatic element of the phenotype--the defect in rhoptry neck formation--is most likely primarily responsible for the loss of invasive capacity in the mutants. Absence of the neck structure would presumably prevent docking and fusion of the rhoptries with the parasite plasma membrane at the merozoite apical prominence, reducing or ablating the capacity for rhoptry discharge. It might be expected that loss of the rhoptry neck structure would also result in a phenotype similar to that of loss of TgARO \[[@ppat.1008049.ref048], [@ppat.1008049.ref049]\], with the rhoptries becoming dispersed throughout the merozoite cytoplasm rather than apically located; however the relatively small dimensions of the *P*. *falciparum* merozoite relative to the *Toxoplasma* tachyzoite likely limits cytoplasmic movement of untethered rhoptries, rendering this phenotype less obvious.

In conclusion, the selective impact of RAMA disruption on the correct localisation of some but not all rhoptry proteins supports the existence of subsets of rhoptry proteins, some of which require RAMA for correct trafficking whilst others do not. We have shown that RAMA disruption is lethal, likely through a direct impact upon rhoptry biogenesis and a resulting indirect impact upon invasion but not egress. Given that there is no obvious orthologue of RAMA in *Toxoplasma* and other apicomplexan parasites outside of the *Plasmodium* genus, our findings raise obvious questions as to how rhoptry neck formation is regulated in other Apicomplexa. In this regard is interesting to note that disruption of the gene encoding a GPI-anchored *Toxoplasma* rhoptry bulb protein called TgCA_RP results in dysmorphic, fragmented rhoptries \[[@ppat.1008049.ref064]\], although the phenotype is quite different from that of the RAMAΔE2 *P*. *falciparum* mutants and the morphologies of rhoptries are also distinct between the two apicomplexan genera. TgCA_RP and RAMA share no homology, but it is conceivable that the roles of the two proteins in rhoptry biogenesis may be similar.

Materials and methods {#sec009}
=====================

Ethics statement {#sec010}
----------------

This work used human blood that was provided anonymously through the UK Blood Transfusion Service.

Reagents and antibodies {#sec011}
-----------------------

Oligonucleotide primers (see [S1 Table](#ppat.1008049.s003){ref-type="supplementary-material"}) were purchased from Sigma-Aldrich (Gillingham, UK). Rapamycin was also obtained from Sigma-Aldrich and stored frozen as a stock solution (10 μM) in DMSO. The antifolate drug WR99210 (Jacobus Pharmaceuticals, Princeton, NJ) was stored as a 20 μM stock solution in DMSO. The anti-RAMA-D, anti-RhopH3 and anti-KAHRP antibodies were kind gifts of Ross Coppel (Monash University, Australia) whilst Osamu Kaneko (Nagasaki University, Japan) kindly provided antibodies against RhopH1/Clag3.1. The polyclonal anti-AMA1 antibody has previously been described \[[@ppat.1008049.ref065]\], as has the RhopH2-specific mAb 61.3 \[[@ppat.1008049.ref066]\]. The anti-MSP1 mAb 89.1, the anti-RON3 mAb 1H1, the anti-RAP1 mAb 4F3, a rabbit anti-ARO polyclonal antibody, and rabbit antibodies against RON12 were kind gifts of Tony Holder (Francis Crick Institute, UK), and the antibodies to Rh2b were generously provided by Julian Rayner (University of Cambridge, UK). Other antibodies were generously provided by John Vakonakis, University of Oxford, UK (anti-MAHRP1 antibody), Simon Draper, University of Oxford, UK (anti-Rh5 antibody), Takafumi Tsuboi, Ehime University Japan (anti-RON2 antibody) and Jean-François Dubremetz, Université Montpellier 2, France (anti-RON4 mAb 24C6).

Generation of RAMA conditional mutant parasite lines {#sec012}
----------------------------------------------------

*RAMAloxP* mutant *P*. *falciparum* lines were generated by transfecting parasites with 60 μg of a repair plasmid alongside 20 μg of a plasmid for expression of Cas9. Repair plasmid pESS_RAMA_E2INT_loxP (synthesised by ThermoFisher Scientific) comprised synthetic heterologous *SERA2*:*loxP* and *SUB2*:*loxP* introns which were inserted at AG-AT sites 776 bp and 952 bp respectively downstream of the *RAMA* gene ATG start codon. The intervening 174 bp was codon-optimised for expression in *Escherichia coli*. Sequence comprising 568 bp of exon 2 both 5' and 3' to the site of the heterologous intron insertions was included to act as flanking regions for homologous recombination. EuPaGDT software was used to identify 20 bp protospacer sequences (flanked by a 5'-NGG-3' protospacer adjacent motif) in order to specifically target Cas9-mediated cleavage to the *RAMA* gene locus. pRAMAsgRNA1 and pRAMAsgRNA2 were created by modifying the Cas9-sgRNA-encoding pDC2 vector (a kind gift of Marcus Lee, Sanger Institute, UK) by introduction of sgRNAs 1 and 2 generated by annealing complementary primer sequences RAMA_sgRNA_E2_F to RAMA_sgRNA_E2_R (sgRNA1), and RAMA_sgRNA_E2S_F to RAMA_sgRNA_E2S_R (sgRNA2).

*P*. *falciparum* cell culture, transfection and cloning {#sec013}
--------------------------------------------------------

All parasite work described used the 3D7-derived DiCre-expressing 1G5DiCre (1G5DC) *P*. *falciparum* clone \[[@ppat.1008049.ref044]\]. Parasites were maintained in culture and synchronised using standard procedures \[[@ppat.1008049.ref067], [@ppat.1008049.ref068]\]. DNA constructs were introduced by electroporation into mature schizont-stage 1G5DC parasites using previously described methods \[[@ppat.1008049.ref069]\]. Approximately 24 h post-transfection the cultures were supplemented with WR99210 (2.5 nM) to allow selection of parasites carrying the human *dhfr* selectable marker encoded by the pRAMAsgRNA plasmids. Parasites were maintained under drug selection for 2 erythrocytic cycles before being transferred to drug-free culture medium. Following confirmation of integration in the resulting parasite populations by diagnostic PCR, parasites were cloned by limiting dilution \[[@ppat.1008049.ref046]\]. Conditional excision of floxed genomic sequences in the transgenic parasite clones was induced as previously described \[[@ppat.1008049.ref044]\] by treating tightly synchronized ring stage parasite cultures with 100 nM RAP in 1% (v/v) DMSO (or the same concentration of DMSO only as a vehicle control) for 4 h at 37°C.

Detection of integration and excision events by diagnostic PCR, Southern blotting and immunoblotting {#sec014}
----------------------------------------------------------------------------------------------------

5ʹ and 3ʹ integration of pESS_RAMA_E2INT_loxP into the genome was detected by PCR using the integration specific primers RAMA_exon1_F plus RAMA_exon2recod_R, and RAMA_exon2recod_F plus RAMA_exon2_R. No amplification was expected from the wild type specific primer set RAMA_exon1_F plus RAMA_exon2WT_R. Diagnostic PCR was also used to confirm that the integrated DiCre expression cassette remained unmodified in isolated clones, using primers SERA5_DiCre_F and DiCre_integrated. Reversion to the wild type *SERA5* locus by spontaneous excision of the integrated DiCre cassette (which can occur at low levels in the 1G5DC line; \[[@ppat.1008049.ref004]\]) was indicated by the amplification of a 1700 bp amplicon using primers specific to the unmodified *SERA5* locus (SERA5_DiCre_F and SERA5_DiCre_R). To further confirm the genotype of potential *RAMAloxP* integrant clones, a 400 bp digoxigenin (DIG)-labelled probe corresponding to the 5' 400 bp of the region of exon 2 used as the second homology arm was generated by PCR amplification using primers RAMA_SB_homology2_F and RAMA_SB_homology2_R, performed in the presence of DIG-labelled nucleotides provided by the PCR DIG Labelling Mix Plus (Roche). Approximately 5 μg of gDNA from putative integrant cultures was digested with an excess of XmnI restriction enzyme, then fractionated by agarose gel electrophoresis, transferred overnight to Amersham Hybond N+ nylon membranes (GE Healthcare Life Sciences), and cross-linked with UV light (1200 μjoules/cm^2^). After pre-hybridisation, hybridisation, washing and blocking steps, hybridised signal was detected by incubation with polyclonal alkaline phosphate-conjugated anti-DIG antibodies (Roche). The membrane was incubated with detection buffer and CDP-star (Roche), before being exposed to X-ray film. RAP-induced recombination between genomic *loxP* sites was detected by PCR analysis of schizont-stage gDNA (harvested 42--44 h following mock- or RAP-treatment) using primers RAMA_Harm1_F and RAMA_Harm2_R. For immunoblot analysis, SDS-PAGE fractionated proteins were transferred to nitrocellulose membranes before being blocked, incubated with primary antibody diluted to the appropriate concentration, washed and then probed with a HRP-conjugated secondary antibody as previously described \[[@ppat.1008049.ref065]\]. After final washes, membranes were incubated with Immobilon Western Chemiluminescent HRP Substrate (Merck) and signals visualised by exposure to X-ray film.

Indirect immunofluorescence assays {#sec015}
----------------------------------

Thin blood films of mock- or RAP-treated Percoll-enriched *RAMAloxP* schizonts were air-dried and stored desiccated at -80°C. As required, samples were thawed at 37°C and parasites fixed in 4% (w/v) paraformaldehyde and permeabilised in 0.1% (v/v) Triton X-100. Fixed slides were blocked then probed with the relevant antibody diluted as follows: rabbit anti-RAMA-D, 1:1000; mouse mAb 4F3 (anti-RAP1), 1:100; rabbit anti-RhopH1/Clag3.1, 1:100; mouse mAb MRA876 (anti-RAP2), 1:200; rabbit anti-Rh5, 1:10,000; mouse mAb 61.3 (anti-RhopH2), 1:100; rabbit anti-ARO, 1:500; rabbit anti-RhopH3 (anti-Ag44), 1:2000; rabbit anti-RON2, 1:250; mouse mAb 1H1 (anti-RON3), 1:100; mouse mAb 24C6 (anti-RON4), 1:500; rabbit anti-AMA1, 1:500; mouse mAb 89.1 (anti-MSP1), 1:1000; rabbit anti-RON12, 1:5000; rabbit anti-Rh2b, 1:500. After incubation and washing, slides were probed with the required Alexa Fluor 488 or 594-conjugated secondary antibody diluted 1:10,000. Slides were then mounted in ProLong Gold Antifade Mountant containing DAPI (ThermoFisher Scientific), sealed with Cytoseal-60 (Thermofisher Scientific) and images collected using a Nikon Eclipse Ni-E wide field microscope with a Hamamatsu C11440 digital camera and 100x/1.45NA oil immersion objective. Identical exposure conditions were used at each wavelength for each pair of mock- and RAP-treated samples under comparison. Images were processed using Fiji software.

Parasite growth and invasion assays {#sec016}
-----------------------------------

To determine the growth capability of mutant parasites over multiple cycles, DMSO and RAP-treated cultures were adjusted to a parasitaemia of 0.1%, with samples for flow cytometry being sampled for fixation every 48 h for up to 6 erythrocytic growth cycles. Pelleted parasites were fixed in 4% paraformaldehyde (Electron Microscopy Sciences) and 0.02% glutaraldehyde (Sigma-Aldrich) in PBS for 1 h at 37°C, before being diluted into PBS. When ready for flow cytometry, samples were stained with a 1:10,000 dilution of Hoechst 33342 (ThermoFisher Scientific) in PBS for 30 min at 37°C. The invasive capacity of parasites was determined by adding RBCs to highly synchronous Percoll-purified mature schizonts to obtain a parasitaemia of 1%. After further incubation for 4 h, cultures were fixed and the percentage of newly infected RBCs was determined. Parasitaemia and DNA replication were indicated by Hoechst-staining intensity determined using a LSRFortessa (BD Biosciences) flow cytometer, collecting a minimum of 10^5^ events per sample. Data were analysed using FlowJo software. The relative plaque-forming capacity of parasites was determined as previously described \[[@ppat.1008049.ref046], [@ppat.1008049.ref070]\]. All experiments were performed in triplicate using blood from different donors, and statistical analysis was performed using GraphPad Prism.

Time-lapse video microscopy {#sec017}
---------------------------

To visualise merozoite egress, schizont-stage mock- or RAP-treated parasites were imaged as previously described \[[@ppat.1008049.ref004], [@ppat.1008049.ref069]\]. Invasion videos were similarly performed using schizonts purified from mock- or RAP- treated cultures mixed with fresh uninfected RBCs. DIC images were acquired every 150 ms and Nikon NIS Elements AR analysis software was used to produce the resulting time-lapse videos.

Transmission electron microscopy {#sec018}
--------------------------------

Schizonts of *RAMAloxP* parasites were harvested \~44 h following mock- or RAP-treatment, before being fixed in 2.5% glutaraldehyde and 4% formaldehyde in 0.1 M phosphate buffer. After fixation, cells were washed in 0.1 M phosphate buffer, embedded in 2% agarose and processed as described previously \[[@ppat.1008049.ref004]\].

Statistical analysis of TEM images {#sec019}
----------------------------------

For each sample, three sections were taken from each of three of the 1 mm^3^ blocks of agarose-embedded schizonts. Twenty schizonts from each block were quantified, scoring the number of rhoptries within each intracellular merozoite. Each rhoptry was also visually classified as being circular or club-shaped (i.e. possessing distinct neck and bulb regions). Statistical analyses of the data were performed using R 3.3.1 (<https://www.R-project.org/>) (R Core Team, 2013). Generalised linear models were fit using the glm() function, with the first model (rhoptry_count\~DMSO_or_Rapa_status, family = Poisson) being used to test for a difference in rhoptry counts. For comparison of 'club-shaped' counts on the non-zero rhoptry data, the model used was club_count\~DMSO_or_Rapa_status + rhoptry_count, family = Poisson. Analysis of Deviance was performed using the anova() function on the resultant glm object, with test = 'Chisq'.

Transmission electron tomography {#sec020}
--------------------------------

Tilt series images of a schizont from each experimental condition were collected from +60° to -60° with 1° increments using the Tecnai User Interface software (FEI). The 1024 x 1024 pixel images were recorded with an Ultrascan charge coupled device camera (Gatan Inc.) with a pixel size of 5.42 nm. The IMOD package \[[@ppat.1008049.ref071]\] was used to reconstruct individual tomograms, with patch tracking used to create a fiducial model. For each schizont, tomograms from three serial 200 nm sections were flattened and joined together in z to obtain a continuous volume. The 3dmod programme of IMOD was used to manually segment rhoptry membranes, from which three-dimensional surface models were generated. Models were left open where rhoptries extended outside the joined volume, and where the top or bottom surface of a rhoptry was lost between adjacent tomograms.

Supporting information {#sec021}
======================

###### No significant differences in replication rates of *RAMAloxP P. falciparum* clones and parental 1G5DC parasites over the course of 4 erythrocytic cycles.

Parasitaemia values (quantified by flow cytometry) were averaged from three biological replicate experiments performed using blood from different donors, and are presented as mean ± SD.

(TIF)

###### 

Click here for additional data file.

###### Disruption of RAMA has no effect on subcellular localisation of the rhoptry neck protein RON12 or the rhoptry body and neck protein Rh2b.

IFA showing that the staining profiles of both RON12 and Rh2b were unaltered between DMSO- and RAP-treated *RAMAloxP* clone 9C10 schizonts. Antibodies to RhopH2 were used as a marker for the rhoptry bulb. Scale bar, 5 μm.

(TIF)

###### 

Click here for additional data file.

###### Oligonucleotide primer sequences used in this study.

(PDF)

###### 

Click here for additional data file.

###### Time-lapse video microscopy showing that mock-treated (DMSO-treated) *RAMAloxP* clone 9C10 merozoites bind to and deform RBCs, invade and induce echinocytosis.

(MP4)

###### 

Click here for additional data file.

###### Time-lapse video microscopy showing that RAP-treated, RAMA-deficient *RAMAloxP* clone 9C10 merozoites interact with and deform host RBCs but neither invade nor induce echinocytosis.

(MP4)

###### 

Click here for additional data file.

###### Tomogram video and three-dimensional reconstruction of rhoptries from a mock-treated (DMSO-treated) *RAMAloxP* clone 9C10 schizont (see [Materials and methods](#sec009){ref-type="sec"} for a description of methods used).

(MOV)

###### 

Click here for additional data file.

###### Tomogram video and three-dimensional reconstruction of rhoptries from of a RAP-treated *RAMAloxP* clone 9C10 schizont (see [Materials and methods](#sec009){ref-type="sec"} for a description of methods used).

(MOV)

###### 

Click here for additional data file.
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Dear Mike

Thank you very much for submitting your manuscript \"The Plasmodium falciparum rhoptry bulb protein RAMA plays an essential role in rhoptry neck morphogenesis and host red blood cell invasion\" (PPATHOGENS-D-19-00959) for review by PLOS Pathogens. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some aspects of the manuscript that should be improved.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer. Please pay particular attention to the additional work recommended by reviewer 3 regarding the localisation of additional rhoptry neck marker (RON12, PfRh1, PfRh2a and PfRh2b) to support any general statement as to the localisation of neck proteins in the RAMA mutant.

In addition, when you are ready to resubmit, please be prepared to provide the following:

\(1\) A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

\(2\) Two versions of the manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

We hope to receive your revised manuscript within 60 days or less. If you anticipate any delay in its return, we ask that you let us know the expected resubmission date by replying to this email.

\[LINK\]

If you have any questions or concerns while you make these revisions, please let us know.

Sincerely,

Oliver Billker

Associate Editor

PLOS Pathogens

Vern Carruthers

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

​[orcid.org/0000-0001-5065-158X](http://orcid.org/0000-0001-5065-158X)

Grant McFadden

Editor-in-Chief

PLOS Pathogens

[orcid.org/0000-0002-2556-3526](http://orcid.org/0000-0002-2556-3526)

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Reviewer\'s Responses to Questions

**Part I - Summary**

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer \#1: Apical organelles of merozoites play important roles during host cell invasion. The rhoptries are club-shaped structures with a bulb region that tapers to a narrow neck. Different proteins localize to the rhoptry bulb and neck, but the function of many of these proteins and how they are spatially segregated within the rhoptries is unknown. Using conditional disruption of the gene encoding the GPI-anchored rhoptry bulb protein, rhoptry-associated membrane antigen (RAMA), the Authors demonstrated that RAMA is indispensable for blood stage parasite survival. Contrary to previous reports, RAMA is not required for trafficking of rhoptry bulb proteins. Instead, RAMA-null parasites display selective mislocalization of rhoptry neck proteins (RONs) and produce dysmorphic rhoptries that lack a distinct neck region. The mutant parasites undergo normal intracellular development and egress but display significant defect in invasion and do not induce echinocytosis in target red blood cells. These results clearly proved an important role for RAMA in formation of the rhoptry neck structure. All the works were carefully designed, clearly presented, and the manuscript is well written. I have only a few comments for the improvement of this manuscript.

Reviewer \#2: Apicomplexan parasites have specialized apical organelles such as rhoptries to enable successful invasion into red blood cells. This manuscript by Sherling et al uses a conditional knockdown of RAMA, a rhoptry bulb protein, to understand its contribution to the invasion process. The main conclusions of this paper are that knockdown of RAMA results in a defect in parasite invasion (but not egress), the loss of expression/localization of RON proteins (but not RAP1, AMA1 etc) and malformed rhoptries (from bulb shaped to a more circular morphology).

In general, this paper is very thorough in the presentation of the results and the characterization of the knockdown phenotype. For example, in the generation of the knockdown lines and subsequent phenotyping, the authors use two independent clones and characterize the knockdown in the presence of rapamycin using PCR to show the excision of the relevant genomic locus, Western blotting and IFA to show that the levels of expression are dramatically reduced. While phenotyping the invasion defect, the authors also use 1G5DC which is a non-relevant knockdown as a control. In addition, this paper uses live imaging, IFA and TEM to define that the defect was in invasion and not egress, that RON proteins are missing and that the rhoptries are more likely to not retain a bulb shaped morphology in the knock down lines. In addition, the Discussion is balanced in its interpretation and in the scope of what has been analysed. For example, the knockdown construct that is generated still expresses \~ 220 amino acids at the N -terminus and the authors provide an explaination based on previous results how this residual domain will not interact with complex partners and is no longer membrane-associated. In summary, all relevant controls have been included and a diverse array of tools used to characterize the knockdown phenotype.

My minor recommendations are:

1\. While the characterization of egress, early and late schizont development is complete, it would have been good to have more characterization during attachment in the invasion process. This would involve using isolated merozoites and imaging during the time of attachment, which is challenging. Nevertheless, the main question that could be addressed is: What happens to RAP2, PfRh5, RhopH2/H3, AMA1 when a RAMA-knockdown merozoite contacts a red blood cell (or a select visualisation of some of the proteins)? Do these parasite ligands show surface release onto the red blood cell surface rather than targeted single foci? It would be interesting to observe if the defect to these invasion ligands is similar to the phenotype seen in Figure 6B of Riglar et al., Cell Host & Microbe 2011. The main reason for extending the characterization to merozoites and invasion is that you would be able to further define a potential additional defect in the RAMA-knockdown; that these invasion ligands that are present are also not being "expulsed" in the correct fashion, potentially due to the malformed rhoptries. As the paper currently stands, your main conclusion is a relationship between the lack of RONs and malformed rhoptries.

2\. Invasion ligands are released from the rhoptries and micronemes during invasion. Would it be possible to analyse invasion supernatants for a combination EBAs (micronemal) and PfRhs (rhoptries), to see if these ligands are still released? Or what happens to AMA1? The main rationale for requesting these experiments are similar to the one above, which is to extend how malformed rhoptries contribute to a further defect in invasion separate from RONs that may extend to timing of release and processing of invasion ligands.

3\. First paragraph of Introduction:

i\) "five species of the genus Plasmodium" should be changed to "six species...".

ii\) "Invasion is a stringently orchestrated process", the word stringently should probably be removed as there is significant variation in times of invasion.

4\. The legend in Figure 1F suggests that there is quantitative data for the staining of RAMA in untreated and treated cells. Please include a graph of the anti-RAMA and anti-RAP1 staining in the WT and knockdown cells.

Reviewer \#3: This manuscript assesses the function of the rhoptry protein RAMA in Plasmodium falciparum using conditional disruption of the corresponding gene. The authors show that the rhoptry-associated membrane protein RAMA is indispensable for the invasion process, likely because the rhoptry are not formed properly and not secreted. Previous studies using FRET and immunoprecipitations had shown that RAMA interacts with the rhoptry proteins RAP1 and RhopH3 and serves as an escorter for their proper targeting to the bulb of the rhoptries. Here the authors show that the apical targeting of these particular proteins is unchanged in absence of RAMA, invalidating this presumed function. In contrast the authors provide evidence that in absence of RAMA, RON2, RON4, and RON3 are not associated with mature rhoptries. Finally, insight into the ultrastructural consequences of depleting RAMA revealed its crucial role in the pear-shaped structure of the rhoptry. The wide bulb region remains formed but the elongated neck is missing or abnormal in absence of RAMA.

The study is very well performed and the paper very well written.

How two distinct compartments, the neck versus the bulb, are generated despite the absence ofa any physical barrier remains enigmatic in Apicomplexa. To my knowledge this is the first rhoptry protein described to participate in the formation of the neck of rhoptries in Plasmodium (but also in Apicomplexa in general), without affecting the morphology of the bulb part. This is an important step to move forward into elucidating the mechanistic of the elongation of rhoptry neck.

\*\*\*\*\*\*\*\*\*\*

**Part II -- Major Issues: Key Experiments Required for Acceptance**

Please use this section to detail the key new experiments or modifications of existing experiments that should be [absolutely]{.ul} required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a \"Major Revision\" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend \"Reject\".

Reviewer \#1: Not applicable.

Reviewer \#2: (No Response)

Reviewer \#3: 1. One of the claim of this paper is that RAMA is required for selective trafficking of rhoptry neck proteins, while targeting of bulb proteins is not affected by absence of RAMA. While it is obvious that a subset of rhoptry proteins are not properly targeted, it is not clear whether the defect is selective for rhoptry neck proteins as claimed throughout the manuscript. The authors used too few rhoptry neck markers to generalize their findings. First, two proteins are part of the same complex (RON2, RON4) and second, despite its name, RON3 has actually been shown to be a rhoptry bulb protein in both Plasmodium (Ito et al., Parasitol Int, 2011) and Toxoplasma (Peter's Bradley annotation in ToxoDB). The targeting defect appears therefore not selective for rhoptry neck proteins but also for bulb proteins. Furthermore, conflicting localization of PfRh5 are reported in the literature; in some papers PfRh5 is described as a rhoptry neck (Baum et al., Int J Parasitol 2009), or as a bulb protein (Sony Reddy, PNAS 2015) or in neither of the two (Douglas, J. Immunol. 2014). In summary, in order to get a better picture of the selectivity of RAMA-dependent targeting, the authors are recommended to perform IFAs using additional validated markers for rhoptry neck proteins (RON12, PfRh1, PfRh2a and PfRh2b).

2\. In absence of RAMA, RON2 RON3 and RON4 proteins are visible in immature schizonts and then disappear in fully segmented parasites. This raises the question of whether they are in immature rhoptries together with rhoptry proteins RAP2, ARO, RhopH\...; or if they are stacked in the secretory pathway and then degraded? A co-localization between RON2 (or RON4) and RAP2 (or ARO) will clarify if the block occurs before the proteins reach the rhoptries or once they are in the secretory organelles.

\*\*\*\*\*\*\*\*\*\*

**Part III -- Minor Issues: Editorial and Data Presentation Modifications**

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer \#1: Major Comment:

1\. RON3 \<page 18=\"\"\> & Fig. 4B&C

"Our observation that trafficking of RON3 was impaired in the RAMAΔE2 mutants is intriguing since in fact the Plasmodium orthologue of this protein has been previously localised to the rhoptry bulb \[61\], rather than to the rhoptry neck as originally determined for the Toxoplasma orthologue \[10\]; the current nomenclature for RON3 in Plasmodium may therefore be somewhat misleading."

The original localization of TgRON3 was determined by IFA alone (not IEM) \[10\], so that the evidence of the naming as TgRON3 is weak. In contrast, since localization of PfRON3 in the rhoptry bulb was proved by IEM \[61\], PfRON3 as a rhoptry "bulb" protein is the only reliable localization evidence to date. So PfRON3 should be treated as rhoptry "bulb" protein NOT the rhoptry "neck" protein. Please revise the related text throughout the manuscript. Especially all the IFA images of the RON3 (Fig. 4B&C) are similar to those of RON2 & RON4 (rhoptry "neck" protein).

Minor Comments:

2\. Fig. 4A

Rh5 signal in DMSO control parasite looks weaker (RAP parasite looks stronger). Current description is "n difference". So, please explain.

3\. Page 4 Lines 21-23.

"Egress and invasion involve the regulated discharge of at least four classes of secretory organelles, unique to apicomplexan parasites, that positioned within the apical end of the merozoite."

Rhoptry, microneme, dense granule and what? Please describe 4 classes of secretory organelles with citation.

4\. IFA method (page 23)

Please describe the dilution of each antibodies ("appropriate dilution" is not preferable).

5\. Statistical analysis of TEM images (page 24-25)

"the glm() function", "the anova() function"

What are these mean?

Reviewer \#2: Please refer to the summary above.

Reviewer \#3: 3. Of note, deletion of TgCA_RP in Toxoplasma also induces an unusual shape of the rhoptries (Chasen et al., MSphere 2017), although the phenotype is quite different, and the morphologies of the rhoptries are also quite different between the two Apicomplexa. Interestingly, TgCA_RP is also a GPI-anchored rhoptry protein associated with lipid-raft and its role in maturation of rhoptries is dependent of its GPI anchor. While no homolog of PfRAMA could be identified in T. gondii and RAMA and CARP do not share homologies, their overall mechanism might still be quite similar. This mutant should be introduced in the discussion.

4\. Since this paper does not agree with the previous escort function of RAMA for HMW and LMW rhoptry proteins, immuno EM to obtain a full validation of the presence of RAP1 and RhopH3 in the rhoptry bulbs would have been enlightening but is not required for the central conclusions of the paper.

5\. In discussion the authors noted that their findings may not necessarily be in conflict with a role of RAMA in facilitating formation of the HMW and LMW complexes. This is something that might be easy to test by co-IP using anti-RhopH3 or RAP2 antibodies in RAPA treated parasites.

6\. Figure 4C, despite the reviewer agrees with the conclusion drawn from this panel, the pictures are too small to distinguish between immature schizonts versus fully segmented schizonts. The reviewer suggests to show only representative schizonts in larger magnification in main figure and to move the full fig. 4C as a supplementary figure.

7\. Unless I am mistaken, the number of rhoptries analyzed for the figures 5 is not mentioned.

8\. Page 10. What does "t =115.9, d.f.=4" mean?

 \</page\>

\*\*\*\*\*\*\*\*\*\*

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plospathogens/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No

10.1371/journal.ppat.1008049.r002
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\[EXSCINDED\]

Dear Professor Blackman,

We are pleased to inform that your manuscript, \"The Plasmodium falciparum rhoptry bulb protein RAMA plays an essential role in rhoptry neck morphogenesis and host red blood cell invasion\", has been editorially accepted for publication at PLOS Pathogens. 

Before your manuscript can be formally accepted and sent to production, you will need to complete our formatting changes, which you will receive by email within a week. Please note that your manuscript will not be scheduled for publication until you have made the required changes.

IMPORTANT NOTES

\(1\) Please note, once your paper is accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at <plospathogens@plos.org>.

\(2\) Copyediting and Proofreading: The corresponding author will receive a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. 

\(3\) Appropriate Figure Files: Please remove all name and figure \# text from your figure files. Please also take this time to check that your figures are of high resolution, which will improve the readbility of your figures and help expedite your manuscript\'s publication. Please note that figures must have been originally created at 300dpi or higher. Do not manually increase the resolution of your files. For instructions on how to properly obtain high quality images, please review our Figure Guidelines, with examples at: <http://journals.plos.org/plospathogens/s/figures>.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

\(4\) Striking Image: Please upload a striking still image to accompany your article if one is available (you can include a new image or an existing one from within your manuscript). Should your paper be accepted, this image will be considered for our monthly issue image and may also appear on our website to feature your article. Please upload this as a separate file, selecting \"striking image\" as the file type upon upload. Please also include a separate \"Other\" file with a caption, including credits and any potential copyright information. Please do not include the caption in the main article file. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License at <http://journals.plos.org/plospathogens/s/content-license>. Please note that PLOS cannot publish copyrighted images.

\(5\) Press Release or Related Media: If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team in advance at <plospathogens@plos.org> as soon as possible. We ask that you contact us within one week to plan ahead of our fast Production schedule. If you need to know your paper\'s publication date for related media purposes, you must coordinate with our press team, and your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. 

(6)  PLOS requires an ORCID iD for all corresponding authors on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager.  To do this, go to 'Update my Information' (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager

\(7\) Update your Profile Information: Now that your manuscript has been provisionally accepted, please log into Editorial Manager and update your profile, if needed. Go to <https://www.editorialmanager.com/ppathogens>, log in, and click on the \"Update My Information\" link at the top of the page. Please update your user information to ensure an efficient production and billing process. 

\(8\) LaTeX users only: Our staff will ask you to upload a TEX file in addition to the PDF before the paper can be sent to typesetting, so please carefully review our Latex Guidelines <http://journals.plos.org/plospathogens/s/latex> in the meantime.

(9) If you have associated protocols in protocols.io, please ensure that you make them public before publication to guarantee immediate access to the methodological details.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens. 

Best regards,

Oliver Billker

Associate Editor

PLOS Pathogens

Vern Carruthers

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

​[orcid.org/0000-0001-5065-158X](http://orcid.org/0000-0001-5065-158X)

Grant McFadden

Editor-in-Chief

PLOS Pathogens
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Reviewer Comments (if any, and for reference):

Reviewer\'s Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer \#3: In their revised MS, the authors have addressed my comments from the initial reviews. In particular they have addressed properly my major point about the selectivity of RAMA-dependent targeting and the text has been revised throughout accordingly.

Part II -- Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be

absolutely

required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a \"Major Revision\" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend \"Reject\".

Reviewer \#3: (No Response)

Part III -- Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer \#3: While this is not required for the central conclusions of the paper, the reviewer would like to clarify his "minor" comment 5. The suggestion was not to confirm the interaction between RAMA and the HMW and LMW complexes, but to perform IP using anti RAP2 antibodies in RAMAloxP parasites (+/- rapa) to test if in absence of RAMA, RAP2 protein remains in complex with RAP1 and RAP3. Indeed, as they discussed "RAMA may associate with RhopH3 and RAP1, for example, in order to facilitate formation of the respective HMW and LMW complexes."

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plospathogens/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?

For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#3: No

10.1371/journal.ppat.1008049.r003
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Dear Professor Blackman,

We are delighted to inform you that your manuscript, \"The Plasmodium falciparum rhoptry bulb protein RAMA plays an essential role in rhoptry neck morphogenesis and host red blood cell invasion,\" has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc\...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

​[orcid.org/0000-0001-5065-158X](http://orcid.org/0000-0001-5065-158X)

Grant McFadden

Editor-in-Chief

PLOS Pathogens

[orcid.org/0000-0002-2556-3526](http://orcid.org/0000-0002-2556-3526)
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